Strategic Medical Aesthetics Acquisition Opportunity

Name: Strategic Medical Aesthetics Acquisition Opportunity
Brand: Transworld Business Advisors
Price: 975000 USD
Availability: InStock

Listing Number: 80041-951620

Back to Listings

Listing Details

Price: $975,000

Location: Middlesex County, Massachusetts

Down Payment: $975,000
Sales: $1,284,022
EBITDA: $277,373
Inventory: $0
Furniture, Fixtures, and Equipment: $0
Rent: $10,259
Employees: 7
Year Established: 10
Reason for Selling: Pursuing Other Opportunities

Interested in learning more about this business?

Fill out the form below to gain access to additional information.

First Name*

Last Name*

Email*

Phone Number*

Message

We are committed to safeguarding the privacy of our website visitors and service users. By checking the opt-in box, you agree to Transworld Business Advisors' Privacy Policy and allow business use of your provided data. Message and Data Rates may apply. Message frequency may vary. You can STOP messaging by sending STOP and get more help by sending HELP. Our full privacy policy can be found here: www.tworld.com/trust

I agree to Privacy Terms*

I agree to receive SMS text messages

For More Information About This Listing

Brook Hartnett

(617) 860-4980 [email protected]

View My Listings

Business Description

Opportunity to acquire an established medical aesthetics practice with 10 years of operating history, a broad range of services, and an established patient base. The business is supported by an experienced clinical and administrative team.

The selling owner primarily oversees administrative and back-office functions and intends to transition out following a transaction. The non-selling owner, who serves as a key revenue-generating aesthetic provider, intends to remain with the business, providing important clinical and operational continuity.

The practice operates from an established facility with meaningful capacity for expansion within its existing footprint. Growth opportunities include increasing provider availability, expanding patient volume, improving facility utilization, and further developing service offerings.

With established infrastructure, diversified revenue sources, and key personnel expected to remain, the business is positioned primarily as an EBITDA-driven opportunity for an investor or industry strategic buyer.